George W. Lloyd - 28 Mar 2023 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: EVP, Investments & CLO
Signature: /s/ Sean Weisberg, as Attorney-in-Fact for George W. Lloyd
Issuer symbol: RPRX
Transactions as of: 28 Mar 2023
Net transactions value: -$4,179,295
Form type: 4
Filing time: 30 Mar 2023, 17:52:21 UTC
Previous filing: 27 Feb 2023
Next filing: 06 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	$3,706,130	-100,000	-31%	$37.06	225,000	28 Mar 2023	By GWL 2014 G, LLC	F1
transaction	RPRX	Class A Ordinary Shares	Sale	$473,165	-12,779	-5.7%	$37.03	212,221	29 Mar 2023	By GWL 2014 G, LLC	F2
holding	RPRX	Class A Ordinary Shares						495,860	28 Mar 2023	By GWL 2013 NG, LLC
holding	RPRX	Class A Ordinary Shares						273,960	28 Mar 2023	By IRA
holding	RPRX	Class A Ordinary Shares						130,000	28 Mar 2023	By GWL 2020 G, LLC
holding	RPRX	Class A Ordinary Shares						3,000	28 Mar 2023	Direct
holding	RPRX	Class A Ordinary Shares						4,011	28 Mar 2023	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $37.19 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.31 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.90 to $37.19 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.31 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.